Stryker Q2 Sales Rise 9.4% as Operating Momentum Recovers

Key Facts

1Stryker's Q2 sales rose 9.4% YoY to approximately $6.6 billion, driven by organic growth.

2Adjusted EPS increased 18% to $3.69, with operating margins expanding 170 bps to 27.4%.

Stryker's Q2 2026 sales rose 9.4% year-over-year to approximately $6.6 billion. Seeking Alpha reported that the results were driven by organic growth, signaling a restoration of operating momentum following previous cybersecurity disruptions that had impacted the company's performance.

Adjusted earnings per share increased 18% to $3.69, as operating margins expanded by 170 basis points to reach 27.4%. In equity markets, SYK closed at $282.6 on October 12, 2026, having traded between a session high of $283.65 and a low of $274.5.